Changchun High-Tech Industry Group Co Ltd

CN

CCHNT

Health Care

110.4 ₽

Current price

Strong buy
110.4 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    20 / 1328

  • Position in country

    129 / 7387

  • Return on Assets, %

    16.9

    -2.7

  • Net income margin, %

    30.5

    2.8

  • EBITDA margin, %

    40.1

    10.8

  • Debt to Equity, %

    8

    19.2

  • Intangible assets and goodwill, %

    9.5

    3.6

  • Revenue CAGR 3Y, %

    19.3

    8.5

  • Total Equity change 1Y, %

    18.8

    0

  • Revenue Y, % chg

    9.2

    0.5

  • P/E

    10.6

    22.7

  • P/BV

    2.1

    1.5

  • P/S

    3.2

    2.3

  • EV/S

    3

    2.4

  • EV/EBITDA

    8

    7.4

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    72.4

    51.3

  • Forward P/E

    8.9

    15.6

  • Dividend Yield, %

    3.8

    1.7

  • Forward Dividend Yield, %

    0.2

    0.2

  • Expected dividend per share

    0.3

    0

  • Payout Ratio, %

    39.9

    30.3

  • Dividend Ex Date

    2024-04-18

Get an analytical review of this company

Competitors

Ranks

  • Changchun High-Tech Industry Group Co Ltd

    00%

  • China Resources Sanjiu Medical & Pharmaceutical Co Ltd

    00%

  • CSPC Pharmaceutical Group Ltd

    00%

  • Zhangzhou Pientzehuang Pharmaceutical Co Ltd

    00%

  • Beijing Tongrentang Co Ltd

    00%

  • Yunnan Baiyao Group Co Ltd

    00%

  • Hansoh Pharmaceutical Group Company Ltd

    00%

  • Zhejiang Nhu Co Ltd

    00%

  • Jiangsu Hengrui Pharmaceuticals Co Ltd

    00%

  • Shanghai Fosun Pharmaceutical Group Co Ltd

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    China

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    6596.4

  • Ticker

    000661.SZ

  • ISIN

    CNE0000007J8

  • IPO date

    1996-12-18

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-03-19

  • Date fact. publication of reports

    2023-12-31

Company Description

Changchun High & New Technology Industries (Group) Inc. is a China-based company principally engaged in bio-pharmaceutical and healthcare businesses. The Company’s main products include polyethylene glycol recombinant human growth hormone injection, recombinant human growth hormone, recombinant human follicle stimulating hormone for injection, freeze-dried live attenuated varicella vaccines and rabies vaccines for human use, among other. The Company is also involved in real estate development and property management businesses. The Company operates its business mainly in domestic market.